SPECIAL NOTICE
A -- LAWRENCE LIVERMORE NATIONAL LABORATORY SEEKS LICENSEE TO PRODUCE A OPTICAL PROBE FOR MEDICAL APPLICATIONS
- Notice Date
- 9/2/2004
- Notice Type
- Special Notice
- NAICS
- 238990
— All Other Specialty Trade Contractors
- Contracting Office
- Department of Energy, Lawrence Livermore National Laboratory (DOE Contractor), Industrial Partnerships & Commercialization, 7000 East Avenue L-795, Livermore, CA, 94550
- ZIP Code
- 94550
- Solicitation Number
- Reference-Number-FBO80-04
- Response Due
- 10/8/2004
- Archive Date
- 10/11/2004
- Point of Contact
- Connie Pitcock, Administration, Phone 925-422-1072, Fax 925-423-8988,
- E-Mail Address
-
pitcock1@llnl.gov
- Description
- LAWRENCE LIVERMORE NATIONAL LABORATORY SEEKS LICENSEE TO PRODUCE A OPTICAL PROBE FOR MEDICAL APPLICATIONS Announcement: Lawrence Livermore National Laboratory (LLNL), operated by the University of California under contract with the U.S. Department of Energy (DOE), wants to license its technology pertaining to Medical Optical Probes. Researchers at LLNL have developed a new, minimally invasive diagnostic Optical Probe that can instantly identify abnormal tissue, including cancerous tissue. The Optical Probe removes no tissue and is expected to achieve accuracy levels comparable to surgical biopsies in detecting cancerous cells. The optical probe assembly consists of control unit containing a laser unit, detectors, and control circuitry. Optical fibers emerge from the unit and these optical fibers transmit light to and from the tissue thru a needle probe. This needle probe is smaller than the needle used in routine blood tests. The optical probe assembly also includes a reference optical fiber as part of the fiber optics, which improves the accuracy of the unit by accounting for optical source variations and changes in the fiber optic transmission efficiencies. The successful deployment of this optical probe could provide new, minimally invasive diagnostic tool that could instantly detect cancerous tissue, which would result in a reduction in the amount of unnecessary biopsies and surgeries. Medical professionals estimate this would have the potential to save the U.S. healthcare system over $2 billion annually. This device is protected by one U.S. Patent (#6647285). Note: THIS IS NOT A PROCUREMENT. Companies interested in commercializing LLNL's Medical Optical Probes technology should provide a written statement of interest, which includes the following: 1. Company Name and address. 2. The name, address, and telephone number of a point of contact. 3. A description of corporate expertise and facilities relevant to commercializing this technology. Written responses should be directed to: Lawrence Livermore National Laboratory Industrial Partnerships and Commercialization P.O. Box 808, L-795 Livermore, CA 94551-0808 Attention: FBO 80-04 Please provide your written statement within thirty (30) days from the date this announcement is published to ensure consideration of your interest in LLNL's Medical Optical Probes technology.
- Record
- SN00664051-W 20040904/040902211748 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |